Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ALLTNYSE:AMPXNASDAQ:AVAVNASDAQ:CMPX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALLTAllot Communications$4.85-5.1%$6.76$1.99▼$9.44$191.73M1.25373,048 shs521,216 shsAMPXAmprius Technologies$2.39-6.1%$2.80$0.61▼$4.21$280.67M2.172.11 million shs2.88 million shsAVAVAeroVironment$111.65-5.1%$146.62$110.07▼$236.60$3.32B0.74400,038 shs561,300 shsCMPXCompass Therapeutics$1.46-9.0%$2.76$0.77▼$4.08$201.89M1.4817,976 shs1.73 million shs13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALLTAllot Communications0.00%-17.09%-11.82%-25.50%+104.64%AMPXAmprius Technologies0.00%-14.67%+19.55%-27.29%+4.15%AVAVAeroVironment0.00%-7.67%-17.34%-30.66%-24.00%CMPXCompass Therapeutics0.00%-26.63%-44.27%-6.41%-21.08%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALLTAllot Communications2.2348 of 5 stars3.83.00.00.02.00.80.6AMPXAmprius Technologies3.9383 of 5 stars4.65.00.00.03.91.70.6AVAVAeroVironment2.9752 of 5 stars3.51.00.00.03.32.51.9CMPXCompass Therapeutics2.8795 of 5 stars4.62.00.00.01.73.30.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALLTAllot Communications 3.50Strong Buy$13.00168.04% UpsideAMPXAmprius Technologies 3.13Buy$9.43295.33% UpsideAVAVAeroVironment 3.00Buy$202.4081.28% UpsideCMPXCompass Therapeutics 3.11Buy$13.38816.10% UpsideCurrent Analyst Ratings BreakdownLatest CMPX, AVAV, ALLT, and AMPX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/4/2025CMPXCompass TherapeuticsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$10.00 ➝ $24.004/2/2025CMPXCompass TherapeuticsGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$12.00 ➝ $12.004/2/2025CMPXCompass TherapeuticsLeerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeMarket Perform ➝ Outperform$4.00 ➝ $6.004/1/2025CMPXCompass TherapeuticsLeerink PartnrsSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Strong-Buy4/1/2025CMPXCompass TherapeuticsWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform$8.004/1/2025CMPXCompass TherapeuticsD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$32.00 ➝ $32.003/21/2025AMPXAmprius TechnologiesRoth MkmSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$6.00 ➝ $6.003/21/2025AMPXAmprius TechnologiesOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$14.00 ➝ $15.003/21/2025AMPXAmprius TechnologiesB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$5.00 ➝ $6.003/21/2025AMPXAmprius TechnologiesHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$10.00 ➝ $10.003/5/2025AVAVAeroVironmentJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$230.00 ➝ $190.00(Data available from 4/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALLTAllot Communications$92.20M2.08N/AN/A$1.33 per share3.65AMPXAmprius Technologies$23.57M11.93N/AN/A$0.67 per share3.56AVAVAeroVironment$742.56M4.24$3.04 per share36.73$29.24 per share3.82CMPXCompass Therapeutics$850K237.52N/AN/A$1.17 per share1.25Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALLTAllot Communications-$62.80M-$0.16N/AN/AN/A-26.69%-48.04%-17.03%5/27/2025 (Estimated)AMPXAmprius Technologies-$36.78M-$0.44N/AN/AN/A-245.92%-71.39%-40.04%5/8/2025 (Estimated)AVAVAeroVironment$59.67M$1.1864.1725.09N/A6.39%8.12%6.75%6/25/2025 (Estimated)CMPXCompass Therapeutics-$42.49M-$0.37N/AN/AN/AN/A-32.37%-30.67%5/12/2025 (Estimated)Latest CMPX, AVAV, ALLT, and AMPX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/20/2025Q4 2024AMPXAmprius Technologies-$0.11-$0.10+$0.01-$0.10$7.12 million$10.63 million2/27/2025Q4 2024CMPXCompass Therapeutics-$0.10-$0.11-$0.01-$0.11N/AN/A2/25/2025Q4 2024ALLTAllot Communications-$0.05$0.02+$0.07$0.01$24.40 million$24.91 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALLTAllot CommunicationsN/AN/AN/AN/AN/AAMPXAmprius TechnologiesN/AN/AN/AN/AN/AAVAVAeroVironmentN/AN/AN/AN/AN/ACMPXCompass TherapeuticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALLTAllot Communications0.832.322.06AMPXAmprius TechnologiesN/A3.463.25AVAVAeroVironment0.024.613.36CMPXCompass TherapeuticsN/A31.8431.84Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALLTAllot Communications51.50%AMPXAmprius Technologies5.04%AVAVAeroVironment86.38%CMPXCompass Therapeutics68.43%Insider OwnershipCompanyInsider OwnershipALLTAllot Communications3.40%AMPXAmprius Technologies12.80%AVAVAeroVironment1.27%CMPXCompass Therapeutics28.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALLTAllot CommunicationsN/A39.53 million37.14 millionOptionableAMPXAmprius Technologies50117.93 million92.29 millionOptionableAVAVAeroVironment1,42828.22 million27.86 millionOptionableCMPXCompass Therapeutics20138.28 million98.38 millionNot OptionableCMPX, AVAV, ALLT, and AMPX HeadlinesRecent News About These CompaniesCompass Therapeutics (NASDAQ:CMPX) Stock Price Expected to Rise, HC Wainwright Analyst SaysApril 6 at 8:30 AM | marketbeat.comQ3 EPS Estimates for Compass Therapeutics Cut by WedbushApril 6 at 7:56 AM | marketbeat.comQ2 Earnings Estimate for CMPX Issued By Leerink PartnrsApril 6 at 7:55 AM | marketbeat.comLeerink Partnrs Analysts Reduce Earnings Estimates for CMPXApril 6 at 2:13 AM | americanbankingnews.comCompass Therapeutics (NASDAQ:CMPX) Price Target Raised to $24.00 at HC WainwrightApril 6 at 1:39 AM | americanbankingnews.comWedbush Reduces Earnings Estimates for Compass TherapeuticsApril 5 at 8:42 AM | marketbeat.comCompass Therapeutics (NASDAQ:CMPX) Upgraded at Leerink PartnrsApril 5 at 7:28 AM | marketbeat.comWedbush Predicts Weaker Earnings for Compass TherapeuticsApril 5 at 3:49 AM | americanbankingnews.comQ3 EPS Estimates for Compass Therapeutics Lowered by WedbushApril 5 at 2:37 AM | americanbankingnews.comBrokerages Set Compass Therapeutics, Inc. (NASDAQ:CMPX) PT at $11.38April 5 at 1:05 AM | americanbankingnews.comCompass Therapeutics price target raised to $24 from $10 at H.C. WainwrightApril 4 at 1:42 PM | markets.businessinsider.comGuggenheim Reiterates "Buy" Rating for Compass Therapeutics (NASDAQ:CMPX)April 4 at 11:52 AM | marketbeat.comCompass Therapeutics (NASDAQ:CMPX) Rating Increased to Outperform at Leerink PartnersApril 4 at 8:12 AM | marketbeat.comCompass Therapeutics (NASDAQ:CMPX) Earns Buy Rating from GuggenheimApril 4 at 2:15 AM | americanbankingnews.comCompass Therapeutics Reports Positive Phase 2/3 Trial Results For TovecimigApril 3 at 10:39 PM | nasdaq.comWhy Compass Therapeutics, Inc.’s (CMPX) Stock Is Down 24.55%April 3 at 10:39 PM | aaii.comCompass Therapeutics (NASDAQ:CMPX) Receives Outperform Rating from WedbushApril 3 at 10:31 PM | marketbeat.comLeerink Partners Upgrades Compass Therapeutics (CMPX)April 3 at 3:27 AM | msn.comCompass Therapeutics (CMPX) Receives a Buy from GuggenheimApril 3 at 3:27 AM | markets.businessinsider.comCompass Therapeutics, Inc. (NASDAQ:CMPX) Receives Consensus Rating of "Moderate Buy" from BrokeragesApril 3 at 2:38 AM | marketbeat.comCompass Therapeutics (NASDAQ:CMPX) Earns Outperform Rating from WedbushApril 3 at 1:49 AM | americanbankingnews.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesBYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?By Jeffrey Neal Johnson | March 21, 2025View BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a BuyBy Thomas Hughes | March 12, 2025View NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy3 Defense Stocks Set to Benefit From Increased Military SpendingBy Chris Markoch | March 20, 2025View 3 Defense Stocks Set to Benefit From Increased Military SpendingArcher Aviation Stock Climbs as Midnight eVTOL Nears RealityBy Jeffrey Neal Johnson | March 10, 2025View Archer Aviation Stock Climbs as Midnight eVTOL Nears RealityAmprius Market Gets Amped Up on Growth OutlookBy Thomas Hughes | April 1, 2025View Amprius Market Gets Amped Up on Growth OutlookCMPX, AVAV, ALLT, and AMPX Company DescriptionsAllot Communications NASDAQ:ALLT$4.85 -0.26 (-5.09%) Closing price 04/4/2025 04:00 PM EasternExtended Trading$4.73 -0.12 (-2.47%) As of 04/4/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Allot Communications Ltd. is a provider of leading innovative network intelligence and security solutions for service providers worldwide, enhancing value to their customers. Their solutions are deployed globally for network and application analytics, traffic control and shaping, network-based security services, and more. Allot's multi-service platforms are deployed by over 500 mobile, fixed and cloud service providers and over 1000 enterprises. Their industry leading network-based security as a service solution has achieved over 50% penetration with some service providers and is already used by over 20 million subscribers in Europe.Amprius Technologies NYSE:AMPX$2.38 -0.16 (-6.10%) Closing price 04/4/2025 03:59 PM EasternExtended Trading$2.39 +0.01 (+0.21%) As of 04/4/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Amprius Technologies, Inc. produces and sells ultra-high energy density lithium-ion batteries for mobility applications. The company offers silicon nanowire anode batteries. Its batteries are primarily used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites. The company was incorporated in 2008 and is headquartered in Fremont, California.AeroVironment NASDAQ:AVAV$111.65 -5.94 (-5.05%) Closing price 04/4/2025 04:00 PM EasternExtended Trading$115.00 +3.35 (+3.00%) As of 04/4/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AeroVironment, Inc. designs, develops, produces, delivers, and supports a portfolio of robotic systems and related services for government agencies and businesses in the United States and internationally. It operates through Small Unmanned Aircraft Systems (SUAS), Tactical Missile System (TMS), Medium Unmanned Aircraft Systems (MUAS), and High Altitude Pseudo-Satellite Systems (HAPS) segments. The company supplies UAS, TMS, unmanned ground vehicle, and related services primarily to organizations within the U.S. Department of Defense, other federal agencies, and to international allied governments. It also designs, engineers, tools, and manufactures unmanned aerial and aircraft systems, including airborne platforms, payloads and payload integration, ground control systems, and ground support equipment and other items and services related to unmanned aircraft systems. In addition, the company offers small UAS products, including training, spare parts, product repair, product replacement, and the customer contracted operation. Further, it develops high-altitude pseudo-satellite UAS systems. AeroVironment, Inc. was incorporated in 1971 and is headquartered in Arlington, Virginia.Compass Therapeutics NASDAQ:CMPX$1.46 -0.15 (-9.03%) Closing price 04/4/2025 04:00 PM EasternExtended Trading$1.43 -0.03 (-2.05%) As of 04/4/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases in the United States. The company's lead product candidates include CTX-009, a bispecific antibody that blocks Delta-like ligand 4 a ligand of Notch-1, and vascular endothelial growth factor A signaling pathways, which are critical to angiogenesis and tumor vascularization; and CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137, a key co-stimulatory receptor on immune cells. It also develops CTX-8371, a bispecific inhibitor that targets PD-1 and PD-L1 checkpoint inhibitor antibodies. The company was founded in 2014 and is headquartered in Boston, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 03/31 - 04/04 Newsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential? Conagra Stock Could Thrive as Tariffs Hit Other Sectors Archer Aviation’s Africa Deal Could Boost ACHR Stock The Ecosystem Edge: Joby's Competitive Advantage Advance Auto Parts Stock: A Classic Rebound Play in the Making Intel’s Big Bet on 18A: Will Lip-Bu Tan’s Vision Pay Off? Lamb Weston Stock Rises, Earnings Provide Calm Amidst Chaos Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
